PEN
PEN
NYSE · Health Care

Penumbra Inc

$334.17
-1.39 (-0.41%)
As of Mar 24, 9:42 PM ET ·
Analyst Consensus
Hold
23
Analysts
High
Coverage
Buy 8 35%
Hold 15 65%
Sell 0 0%
Price Target
Analyst Price Target -43.8% upside
Low Target $160.04
Average Target $187.90
High Target $232.77
Current Price $334.17
Current
$334.17
Target
$187.90
$160.04 $187.90 avg $232.77
Scenario Analysis
Bear Case
$160.04
-52.1%
Low target
Base Case
$187.90
-43.8%
Avg target
Bull Case
$232.77
+-30.3%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$362.41
-7.8% from high
52-Week Low
$221.26
+51.0% from low
50-Day SMA
$329.67
+1.4% vs SMA
200-Day SMA
$277.43
+20.5% vs SMA
RSI (14)
21.8
Oversold
Target vs 52W High
$187.90
-48.2% vs high
Peer Consensus — Health Care
Stock Consensus Analysts Buy % Target Upside
UNH
UnitedHealth Group Inc
Buy 34 68% $293.85 +7.9%
ABT
Abbott Laboratories
Buy 35 71% $123.47 +18.7%
ISRG
Intuitive Surgical Inc
Buy 42 69% $219.77 -53.4%
SYK
Stryker Corp
Strong Buy 37 76% $338.36 +3.0%
HCA
Hca Healthcare Inc
Buy 31 58% $118.82 -75.5%
MDT
Medtronic Plc
Buy 38 63% $192.46 +122.3%
MCK
Mckesson Corp
Strong Buy 22 86% $307.39 -65.1%
BSX
Boston Scientific Corp
Strong Buy 40 93% $136.36 +100.1%